Early Osteoporosis Screening Benefits Have Been Proposed
Medical experts now suggest checking bone density during perimenopause rather than waiting until age 65.
Updated on Oct. 6, 2026 in Women’s Health
Live Poll
Do you believe women should begin osteoporosis screening as early as perimenopause?
Medical professionals have recommended shifting osteoporosis screening to the perimenopausal period to address significant bone loss. This guidance suggests that waiting until age 65 to assess bone health often overlooks the rapid mineral density decline that occurs in the years surrounding a woman's final menstrual period.
Why it matters
Up to 30% of women meet the criteria for osteoporosis before age 65, making the traditional wait-and-see approach ineffective for early prevention. Assessing bone density earlier allows for timely intervention to manage bone loss, which is an indefinite condition that requires lifelong care.
Clinical observations indicate women lose on average 10.6% of lumbar spine and 9.1% of hip bone mineral density within 5 years of their final menstrual period. This data highlights why current diagnostic protocols that prioritize age 65 may miss the window for early intervention.
The details
Managing osteoporosis involves a two-phase pharmacological strategy: an initial bone-building agent to increase density, followed by an anti-remodeling drug to sustain those skeletal benefits. Medications such as teriparatide and romosozumab have shown superior efficacy in reducing fracture risk compared to standard bisphosphonates. Treatment plans are highly individualized, balancing specific risk factors like low body weight with long-term maintenance regimens, such as zoledronate administered every five years.
Timeline
Perimenopause is now recommended for beginning osteoporosis screening and intervention.
The 5 years following the final menstrual period represent a critical window for bone density loss.
Age 65 has historically been the conventional age for initial bone density assessment.
Health Landscape
This move towards earlier screening represents a significant shift from the conventional reliance on age-based testing protocols. By targeting the perimenopausal transition, the medical community aims to bridge the gap in preventing fractures before they become a critical health issue.
If you are approaching or currently in perimenopause, it is worth discussing your bone health and the timing of a DXA scan with your physician. Monitoring low body weight and discussing individualized fracture prevention strategies can help you manage your skeletal health proactively.
The takeaway
Because osteoporosis is an indefinite condition, early assessment is the most effective tool for managing long-term skeletal integrity. Ask your doctor about your specific risk factors during perimenopause rather than waiting for conventional screening age guidelines.
Further reading
Learn more about risk factors and diagnostic tests at Women’s Health.
Source note: This article includes information reported by Healio.
Live Poll
Do you believe women should begin osteoporosis screening as early as perimenopause?
